Välkommen till ett medlemsexklusivt webinar med Dr. Max Wolff organiserat av Nätverket för psykedelisk vetenskap! Zoomlänken läggs upp på våra medlemsinterna ytor i god tid inför evenemanget.
Läs mer och bli medlem här: https://www.psykedeliskvetenskap.org/medlem
Biography
Dr. rer. nat. Max Wolff is a psychologist and psychotherapist and currently serves as the Head of Psychotherapy Training and Research at the MIND Foundation. His research is concerned with the psychotherapeutic mechanisms and contextual conditions of psychedelic-occasioned psychological change, and aims to make the findings of psychotherapy research applicable to the practice of psychedelic therapy. As a psychotherapist, Max works with cognitive-behavioral, acceptance-based, and emotion-focused approaches. He directs the MIND Foundation’s APT Program, an international training in psychedelic-augmented psychotherapy for psychotherapists, psychiatrists, and other mental health professionals. He is also involved as a researcher and study therapist in the EPIsoDE trial, a phase 2b clinical trial investigating the safety and efficacy of psilocybin for treatment-resistant depression at the Central Institute of Mental Health (CIMH) Mannheim, Germany, and Charité University Medicine Berlin.
Psychedelic Therapy is Psychotherapy — Connecting the Dots Between Two Fields that Belong Together
In this talk, I make two assumptions based on which I argue that psychedelic therapy is a form of psychotherapy: First, the therapeutic effects of psychedelic therapy mediated by therapeutic experiences. Second, these experiences likely drive the same general change mechanisms that are also active in other forms of psychotherapy: (1) resource activation, (2) problem actuation, (3) clarification, (4) mastery and (5) the therapeutic relationship. Using illustrative patient reports from the EPIsoDE trial (a clinical study testing psilocybin for depression, finished in early 2024), I aim to clarify the value of looking at psychedelic therapy through the lens of empirical
psychotherapy research. I also outline some of the MIND Foundation’s current efforts to connect the dots between psychotherapy research and psychedelic therapy: theoretical integration, practical implementation in the Augmented Psychotherapy Training (APT), qualitative research, and quantitative research.